Oncogene - Table of Contents alert Volume 37 Issue 29

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 37, Issue 29 In this issue Article Brief Communications Also new AOP Article Tocopherols inhibit esophageal carcinogenesis through attenuating NF-κB activation and CXCR3-mediated inflammation Hui Yang, Miao Xu, Fang Lu, Qiannan Zhang, Yongquan Feng et al. Oncogene 2018 37 :3909 - 3923; April 17, 2018; 10.1038/s41388-018-0246-8 Abstract | Full Text APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer Shixiang Wang, Mingming Jia, Zaoke He & Xue-Song Liu Oncogene 2018 37 :3924 - 3936; April 26, 2018; 10.1038/s41388-018-0245-9 Abstract | Full Text SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival J. Y. Liu, Q. H. Zeng, P. G. Cao, D. Xie, F. Yang et al. Oncogene 2018 37 :3937 - 3952; April 17, 2018; 10.1038/s41388-018-0223-2 Abstract | Full Text Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/ß-catenin pathway Chengdong Ji, Lang Yang, Weijing Yi, Dongfang Xiang, Yanxia Wang et al. Oncogene 2018 37 :3953 - 3966; April 17, 2018; 10.1038/s41388-018-0226-z Abstract | Full Text NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth Khaled Seidi, Rana Jahanban-Esfahlan, Hassan Monhemi, Peyman Zare, Babak Minofar et al. Oncogene 2018 37 :3967 - 3980; April 17, 2018; 10.1038/s41388-018-0213-4 Abstract | Full Text Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance Wei Zhou, Wei Sun, Mingo M. H. Yung, Sheng Dai, Yihua Cai et al. Oncogene 2018 37 :3981 - 3997; April 17, 2018; 10.1038/s41388-018-0238-8 Abstract | Full Text Lymphomas driven by Epstein–Barr virus nuclear antigen-1 (EBNA1) are dependant upon Mdm2 Sana AlQarni, Yazeed Al-Sheikh, Donald Campbell, Mark Drotar, Adele Hannigan et al. Oncogene 2018 37 :3998 - 4012; April 25, 2018; 10.1038/s41388-018-0147-x Abstract | Full Text Contribution of three-dimensional architecture and tumor-associated fibroblasts to hepcidin regulation in breast cancer Nicole Blanchette-Farra, Daniel Kita, Anna Konstorum, Lia Tesfay, David Lemler et al. Oncogene 2018 37 :4013 - 4032; April 26, 2018; 10.1038/s41388-018-0243-y Abstract | Full Text ACTN4 regulates the stability of RIPK1 in melanoma Yuan Yuan Zhang, Hessam Tabataba, Xiao Ying Liu, Jia Yu Wang, Xu Guang Yan et al. Oncogene 2018 37 :4033 - 4045; April 30, 2018; 10.1038/s41388-018-0260-x Abstract | Full Text Brief Communications Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition Albana Gattelli, Martín E. García Solá, Tim C. Roloff, Robert D. Cardiff, Edith C. Kordon et al. Oncogene 2018 37 :4046 - 4054; April 26, 2018; 10.1038/s41388-018-0235-y Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.